MARKET

CTXRW

Citius Pharmaceuticals Inc
CTXRW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-1.5559
-
0.1791
-
Citius Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Citius Pharmaceuticals Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of 6 cents per share. The average analyst rating on the company's shares is "buy" Citius pharmaceuticals Inc shares had fallen by 10.1% this quarter.
Reuters · 02/14 23:57
Citius Pharmaceuticals Inc <CTXR.OQ> expected to post earnings of 13 cents a share - Earnings Preview
Citius Pharmaceuticals Inc expected to post earnings of 13 cents a share. The Cranford New Jersey-based company is expected to report revenue of $21.295 million for the period ending December 31 2023. Average analyst rating on the shares is "buy"
Reuters · 02/06 11:04
Citius Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Citius Pharmaceuticals Inc reports results for the quarter ended in September. The company reported a quarterly adjusted loss of 8 cents per share. The mean expectation of two analysts was for a loss of 7 cents. The average analyst rating on the company's shares is "buy"
Reuters · 12/29/2023 23:27
Citius Pharmaceuticals Inc <CTXR.OQ> expected to post a loss of 2 cents a share - Earnings Preview
Citius Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview. The company is expected to show change in quarterly revenue when it reports results on December 20. LSEG's mean analyst estimate for the company is for a quarterly loss of 2 cents per share.
Reuters · 12/18/2023 11:03
BUZZ-U.S. STOCKS ON THE MOVE-Asbury, natgas firms, energy firms
Reuters · 09/08/2023 15:46
BUZZ-Citius Pharma up on plans to resubmit marketing application for cancer drug
Reuters · 09/08/2023 13:38
BRIEF-Citius Pharmaceuticals Inc. Reports Fiscal Second Quarter 2023 Financial Results
Reuters · 05/12/2023 20:38
BRIEF-Citius Pharmaceuticals Advances Efforts To Spin Off Oncology Asset
Reuters · 03/30/2023 14:18
More

Webull offers Citius Pharmaceuticals Inc stock information, including NASDAQ: CTXRW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTXRW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTXRW stock methods without spending real money on the virtual paper trading platform.